Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy
- PMID: 19689339
- DOI: 10.2174/138161209788923877
Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy
Abstract
Certain characteristics of tumor cells make it possible to develop rational strategies for targeting tumors without harming normal cells. These include the presence of cell surface molecules that characterize the current state of the tumor (e.g. CD30 on Hodgkin lymphoma cells) and the genetic and epigenetic changes that activate oncogenes and inactivate tumor suppressor genes (e.g. the inactivation of tumor suppressor gene DAPK2 in Hodgkin lymphoma cells, which blocks apoptosis). We have developed a novel tumor-targeting fusion protein by combining a selective ligand (CD30L) with a constitutively active version of DAPK2 (DAPK2'-CD30L), thus increasing tumor specificity and reducing systemic toxicity. We showed that this immunokinase fusion protein induces apoptosis specifically in CD30(+)/DAPK2(-) tumor cells in vitro and significantly prolonged overall survival in a disseminated Hodgkin lymphoma xenograft SCID mouse model. Therapeutic strategies based on the cell-specific restoration of a defective, tumor-suppressing kinase demonstrate the feasibility of targeted therapy using recombinant immunokinases.
Similar articles
-
Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.Biomedicines. 2017 Oct 4;5(4):59. doi: 10.3390/biomedicines5040059. Biomedicines. 2017. PMID: 28976934 Free PMC article. Review.
-
Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells.J Immunother. 2009 Jun;32(5):431-41. doi: 10.1097/CJI.0b013e31819f1cb6. J Immunother. 2009. PMID: 19609235
-
Ki-4(scFv)-ETA', a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice.Blood. 2000 Jun 15;95(12):3909-14. Blood. 2000. PMID: 10845927
-
Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.Int J Cancer. 1995 Oct 9;63(2):238-44. doi: 10.1002/ijc.2910630216. Int J Cancer. 1995. PMID: 7591211
-
CD30 as a therapeutic target for lymphoma.BioDrugs. 2014 Apr;28(2):181-209. doi: 10.1007/s40259-013-0068-8. BioDrugs. 2014. PMID: 24043362 Review.
Cited by
-
A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.J Biomed Biotechnol. 2010;2010:187621. doi: 10.1155/2010/187621. Epub 2010 Feb 24. J Biomed Biotechnol. 2010. PMID: 20204062 Free PMC article.
-
Identification of Novel Death-Associated Protein Kinase 2 Interaction Partners by Proteomic Screening Coupled with Bimolecular Fluorescence Complementation.Mol Cell Biol. 2015 Oct 19;36(1):132-43. doi: 10.1128/MCB.00515-15. Print 2016 Jan 1. Mol Cell Biol. 2015. PMID: 26483415 Free PMC article.
-
Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia.MAbs. 2015;7(2):390-402. doi: 10.1080/19420862.2015.1007818. MAbs. 2015. PMID: 25760770 Free PMC article.
-
Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.Biomedicines. 2017 Oct 4;5(4):59. doi: 10.3390/biomedicines5040059. Biomedicines. 2017. PMID: 28976934 Free PMC article. Review.
-
Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells.Oncotarget. 2019 Jan 25;10(8):897-915. doi: 10.18632/oncotarget.26618. eCollection 2019 Jan 25. Oncotarget. 2019. PMID: 30783518 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical